![Michael Ferraresso](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Ferraresso
Corporate Officer/Principal bei AVEO PHARMACEUTICALS, INC.
Aktive Positionen von Michael Ferraresso
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2017 | - |
Geschäftsführer | 01.12.2017 | - |
Karriereverlauf von Michael Ferraresso
Ehemalige bekannte Positionen von Michael Ferraresso
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERASTEM, INC. | Corporate Officer/Principal | 24.01.2017 | 01.11.2017 |
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2013 | 01.01.2017 |
Ausbildung von Michael Ferraresso
Assumption College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERASTEM, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
AVEO Pharmaceuticals, Inc.
![]() AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Michael Ferraresso
- Erfahrung